And in non-small-cell lung cancer tumor-initiating cells, CBX3 and H3K9me3 are significantly increased and inhibited DNA damage related to antineoplastic therapy efficacy [34]. This evidence concerns the gene CBX3 and non-small cell lung carcinoma.